Article about gene therapy in de VolkskrantJanuary 21, 2020
Successful Preclinical Development of Gene Therapy for RAG1-SCIDApril 28, 2020
An article has recently been published by one of the Recomb partners, Sheba in the Journal of Clinical Immunology where they presented the clinical, immunological, and prognostic analysis of a large cohort of RAG1/2-Deficient SCID Patients. The authors emphasized the importance of immediate precautions, an urge for curative treatment and the implementation of the newborn screening for SCID. Read the article here.